-
Je něco špatně v tomto záznamu ?
Measurement of protein synthesis: in vitro comparison of (68)Ga-DOTA-puromycin, [ (3)H]tyrosine, and 2-fluoro-[ (3)H]tyrosine
S. Eigner, DR. Beckford Vera, M. Fellner, NS. Loktionova, M. Piel, F. Melichar, F. Rösch, TL. Roß, O. Lebeda, KE. Henke,
Jazyk angličtina Země Německo
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
- MeSH
- experimentální nádory metabolismus MeSH
- heterocyklické sloučeniny monocyklické chemie MeSH
- krysa rodu rattus MeSH
- pozitronová emisní tomografie MeSH
- proteosyntéza * účinky léků MeSH
- puromycin diagnostické užití MeSH
- radiofarmaka chemická syntéza diagnostické užití MeSH
- radioizotopy galia diagnostické užití izolace a purifikace MeSH
- tritium diagnostické užití MeSH
- tyrosin metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
AIM: Puromycin has played an important role in our understanding of the eukaryotic ribosome and protein synthesis. It has been known for more than 40 years that this antibiotic is a universal protein synthesis inhibitor that acts as a structural analog of an aminoacyl-transfer RNA (aa-tRNA) in eukaryotic ribosomes. Due to the role of enzymes and their synthesis in situations of need (DNA damage, e.g., after chemo- or radiation therapy), determination of protein synthesis is important for control of antitumor therapy, to enhance long-term survival of tumor patients, and to minimize side-effects of therapy. Multiple attempts to reach this goal have been made through the last decades, mostly using radiolabeled amino acids, with limited or unsatisfactory success. The aim of this study is to estimate the possibility of determining protein synthesis ratios by using (68)Ga-DOTA-puromycin ((68)Ga-DOTA-Pur), [(3)H]tyrosine, and 2-fluoro-[(3)H]tyrosine and to estimate the possibility of different pathways due to the fluorination of tyrosine. METHODS: DOTA-puromycin was synthesized using a puromycin-tethered controlled-pore glass (CPG) support by the usual protocol for automated DNA and RNA synthesis following our design. (68)Ga was obtained from a (68)Ge/(68)Ga generator as described previously by Zhernosekov et al. (J Nucl Med 48:1741-1748, 2007). The purified eluate was used for labeling of DOTA-puromycin at 95°C for 20 min. [(3)H]Tyrosine and 2-fluoro-[(3)H]tyrosine of the highest purity available were purchased from Moravek (Bera, USA) or Amersham Biosciences (Hammersmith, UK). In vitro uptake and protein incorporation as well as in vitro inhibition experiments using cycloheximide to inhibit protein synthesis were carried out for all three substances in DU145 prostate carcinoma cells (ATCC, USA). (68)Ga-DOTA-Pur was additionally used for μPET imaging of Walker carcinomas and AT1 tumors in rats. Dynamic scans were performed for 45 min after IV application (tail vein) of 20-25 MBq (68)Ga-DOTA-Pur. RESULTS: No significant differences in the behavior of [(3)H]tyrosine and 2-fluoro-[(3)H]tyrosine were observed. Uptake of both tyrosine derivatives was decreased by inhibition of protein synthesis, but only to a level of 45-55% of initial uptake, indicating no direct link between tyrosine uptake and protein synthesis. In contrast, (68)Ga-DOTA-Pur uptake was directly linked to ribosomal activity and, therefore, to protein synthesis. (68)Ga-DOTA-Pur μPET imaging in rats revealed high tumor-to-background ratios and clearly defined regions of interest in the investigated tumors. SUMMARY: Whereas the metabolic pathway of (68)Ga-DOTA-Pur is directly connected with the process of protein synthesis and shows high tumor uptake during μPET imaging, neither [(3)H]tyrosine nor 2-fluoro-[(3)H]tyrosine can be considered useful for determination of protein synthesis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13024339
- 003
- CZ-PrNML
- 005
- 20130709105107.0
- 007
- ta
- 008
- 130703s2013 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/978-3-642-27994-2_14 $2 doi
- 035 __
- $a (PubMed)22918764
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Eigner, Sebastian $u Department of Radiopharmaceuticals, Academic of Sciences of the Czech Republic, Rez, Czech Republic. eigner@ujf.cas.cz
- 245 10
- $a Measurement of protein synthesis: in vitro comparison of (68)Ga-DOTA-puromycin, [ (3)H]tyrosine, and 2-fluoro-[ (3)H]tyrosine / $c S. Eigner, DR. Beckford Vera, M. Fellner, NS. Loktionova, M. Piel, F. Melichar, F. Rösch, TL. Roß, O. Lebeda, KE. Henke,
- 520 9_
- $a AIM: Puromycin has played an important role in our understanding of the eukaryotic ribosome and protein synthesis. It has been known for more than 40 years that this antibiotic is a universal protein synthesis inhibitor that acts as a structural analog of an aminoacyl-transfer RNA (aa-tRNA) in eukaryotic ribosomes. Due to the role of enzymes and their synthesis in situations of need (DNA damage, e.g., after chemo- or radiation therapy), determination of protein synthesis is important for control of antitumor therapy, to enhance long-term survival of tumor patients, and to minimize side-effects of therapy. Multiple attempts to reach this goal have been made through the last decades, mostly using radiolabeled amino acids, with limited or unsatisfactory success. The aim of this study is to estimate the possibility of determining protein synthesis ratios by using (68)Ga-DOTA-puromycin ((68)Ga-DOTA-Pur), [(3)H]tyrosine, and 2-fluoro-[(3)H]tyrosine and to estimate the possibility of different pathways due to the fluorination of tyrosine. METHODS: DOTA-puromycin was synthesized using a puromycin-tethered controlled-pore glass (CPG) support by the usual protocol for automated DNA and RNA synthesis following our design. (68)Ga was obtained from a (68)Ge/(68)Ga generator as described previously by Zhernosekov et al. (J Nucl Med 48:1741-1748, 2007). The purified eluate was used for labeling of DOTA-puromycin at 95°C for 20 min. [(3)H]Tyrosine and 2-fluoro-[(3)H]tyrosine of the highest purity available were purchased from Moravek (Bera, USA) or Amersham Biosciences (Hammersmith, UK). In vitro uptake and protein incorporation as well as in vitro inhibition experiments using cycloheximide to inhibit protein synthesis were carried out for all three substances in DU145 prostate carcinoma cells (ATCC, USA). (68)Ga-DOTA-Pur was additionally used for μPET imaging of Walker carcinomas and AT1 tumors in rats. Dynamic scans were performed for 45 min after IV application (tail vein) of 20-25 MBq (68)Ga-DOTA-Pur. RESULTS: No significant differences in the behavior of [(3)H]tyrosine and 2-fluoro-[(3)H]tyrosine were observed. Uptake of both tyrosine derivatives was decreased by inhibition of protein synthesis, but only to a level of 45-55% of initial uptake, indicating no direct link between tyrosine uptake and protein synthesis. In contrast, (68)Ga-DOTA-Pur uptake was directly linked to ribosomal activity and, therefore, to protein synthesis. (68)Ga-DOTA-Pur μPET imaging in rats revealed high tumor-to-background ratios and clearly defined regions of interest in the investigated tumors. SUMMARY: Whereas the metabolic pathway of (68)Ga-DOTA-Pur is directly connected with the process of protein synthesis and shows high tumor uptake during μPET imaging, neither [(3)H]tyrosine nor 2-fluoro-[(3)H]tyrosine can be considered useful for determination of protein synthesis.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a radioizotopy galia $x diagnostické užití $x izolace a purifikace $7 D005710
- 650 _2
- $a heterocyklické sloučeniny monocyklické $x chemie $7 D006573
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a experimentální nádory $x metabolismus $7 D009374
- 650 _2
- $a pozitronová emisní tomografie $7 D049268
- 650 12
- $a proteosyntéza $x účinky léků $7 D014176
- 650 _2
- $a puromycin $x diagnostické užití $7 D011691
- 650 _2
- $a radiofarmaka $x chemická syntéza $x diagnostické užití $7 D019275
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a tritium $x diagnostické užití $7 D014316
- 650 _2
- $a tyrosin $x metabolismus $7 D014443
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Beckford Vera, Denis R $u -
- 700 1_
- $a Fellner, Marco $u -
- 700 1_
- $a Loktionova, Natalia S $u -
- 700 1_
- $a Piel, Markus $u -
- 700 1_
- $a Melichar, Frantisek $u -
- 700 1_
- $a Rösch, Frank $u -
- 700 1_
- $a Roß, Tobias L $u -
- 700 1_
- $a Lebeda, Ondrej $u -
- 700 1_
- $a Henke, Katerina Eigner $u -
- 773 0_
- $w MED00005233 $t Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer $x 0080-0015 $g Roč. 194(2013), s. 269-83
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22918764 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20130709105529 $b ABA008
- 999 __
- $a ok $b bmc $g 988019 $s 822719
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 194 $d 269-83 $i 0080-0015 $m Recent Results in Cancer Research $n Recent Results Cancer Res $x MED00005233
- LZP __
- $a Pubmed-20130703